San Clemente, CA, April 13, 2021 (GLOBE NEWSWIRE) via NewMediaWire Global WholeHealth Partners Corp (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests, attains breakthrough on rising neurological disease. "This could simply be described as nothing short of a Medical Breakthrough in Parkinson's Disease Diagnostic Testing for us." said Charles Strongo, CEO of Global WholeHealth Partners, Corp (OTC:GWHP). Global WholeHealth Partners now has the means to identify and test for Parkinson’s disease using a Micro-Well Reader or Lateral Flow Test to measure the certain brain enzymes during the data collection process used in a positive diagnosis. This was disclosed in an 8K filing which can be found by clicking here. Filed on 03/21/2021 “We believe this announcement couldn’t come at a better time for us as we are right in the middle of Parkinson’s Awareness Month,” said Mr. Strongo. “I just read an artic
Medical Breakthrough in Parkinson’s Disease Diagnostics Attained by Global WholeHealth Partners, Corp (OTC: GWHP) as Leading Researcher Believes a Parkinson’s Epidemic is on the Horizon Global WholeHealth Partners Corp.
San Clemente, CA, April 13, 2021 (GLOBE NEWSWIRE) via
NewMediaWire Global WholeHealth Partners Corp (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests, attains breakthrough on rising neurological disease. This could simply be described as nothing short of a Medical Breakthrough in Parkinson s Disease Diagnostic Testing for us. said Charles Strongo, CEO of Global WholeHealth Partners, Corp (OTC:GWHP).
Global WholeHealth Partners now has the means to identify and test for Parkinson’s disease using a Micro-Well Reader or Lateral Flow Test to measure the certain brain enzymes during the data collection process used in a positive diagnosis. This was disclosed in an 8K filing which can be found by clicking here. Fil
Email: Sales@gwhpcorp.com
Forward-Looking Statements
This press release contains forward-looking statements. Such statements may be preceded by the words intends, may, will, plans, expects, anticipates, projects, predicts, estimates, aims, believes, hopes, potential or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of
Global WholeHealth Partners, Corp (OTC:GWHP) Secures Global Distribution Rights to Sell the AstraZeneca COVID-19 Vaccine Anywhere in the World Pending FDA Approval as Biden Administration Stockpiles Vaccine theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
/EIN News/ San Clemente, CA, March 17, 2021 (GLOBE NEWSWIRE) via
NewMediaWire Global WholeHealth Partners Corp. (OTC:GWHP), a multinational supplier of over 70+ FDA approved tests including Dengue, Ebola, Zika, Malaria and also offering one of the largest lines of tests for CoViD19 SARS2, is prepared to help in the fight against CoViD19 SARS2. With the vaccine rollout in progress, continued testing for COVID-19 is imperative and needs to remain a top priority to stop the spread of this deadly virus.
Global WholeHealth Partners, Corp (OTC:GWHP) Secures Distribution Rights to sell the AstraZeneca COVID-19 Vaccine anywhere in the world pending FDA Approval as Biden Administration Increases Stockpile in preparation of a quick roll out.